QUADRA-PE study will evaluate the safety and effectiveness of the Katana™ Thrombectomy System LOS GATOS, Calif., Nov. 4, 2024 /PRNewswire/ — Akura Medical, a Shifamed portfolio company focused on reshaping the landscape of venous thromboembolism (VTE) care, announced today the US Food…
Tag: Akura Medical
Akura Medical, a Shifamed Portfolio Company, Closes $35M in Series B Financing
LOS GATOS, Calif., October 3, 2023 – Akura Medical, a Shifamed portfolio company focused on a differentiated approach to effectively address the major challenges of venous thromboembolism (VTE), announced today the closing of its $35M Series B financing. The funds will […]
Akura Medical Announces Successful First-in-Human Use of its High Performance Mechanical Thrombectomy Platform
Initial cases, proctored by 2 leading US interventionalists, mark the first use of mechanical thrombectomy for pulmonary embolism in the Republic of Georgia Akura’s platform, which will be featured at PCR Innovator’s Day, uses a differentiated approach to deliver high performance […]
Akura Medical, A Shifamed Portfolio Company, Appoints Murali Srivathsa as President and CEO
Company advances its next-generation thrombectomy device CAMPBELL, Calif., April 19, 2022 /PRNewswire/ — Akura Medical, Inc., a Shifamed portfolio company, announced today that seasoned medtech executive, Murali Srivathsa, has joined as President and CEO. With over two decades of industry experience, Murali brings a wealth […]